From high hopes of an INR 6,250 Cr IPO to its current beleaguered state — PharmEasy’s fortunes have swung wildly in less than a year Inc42 has learnt that the company has reduced its workforce by over ...
Indian online pharmacy PharmEasy is now being valued at about $456 million after its investor Janus Henderson said in a filing that it valued its stake of 12.9 million shares in the startup at ...
The CCI approved subscription to CCPS class B shares of API Holdings, the parent of PharmEasy, by MEMG LLP and 360 ONE With this, Ranjan Pai will emerge as one of the biggest investors in PharmEasy ...
Indian online pharmacy startup PharmEasy, once valued at a lofty $5.6 billion, is still about 92% below its peak valuation, according to new estimates by its investor Janus Henderson. The British ...
Indian digital healthcare company API Holdings has refinanced a high-cost loan at an attractive rate through unrated and unlisted bonds, underscoring the growing importance of the private credit ...
MUMBAI, July 19 (Reuters) - Indian drug and medical services startup PharmEasy is in talks with investors to raise $200 million, but at a valuation that could be 15% or even 25% lower than last year's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results